Ausgabe 6/2024
Inhalt (14 Artikel)
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
- Guidelines
George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Haitao Zhao, Motoyuki Otsuka, Sadahisa Ogasawara, Jacob George, Pierce K. H. Chow, Jianqiang Cai, Shuichiro Shiina, Naoya Kato, Osamu Yokosuka, Kyoko Oura, Thomas Yau, Stephen L. Chan, Ming Kuang, Yoshiyuki Ueno, Minshan Chen, Ann-Lii Cheng, Gregory Cheng, Wan-Long Chuang, Oidov Baatarkhuu, Feng Bi, Yock Young Dan, Rino A. Gani, Atsushi Tanaka, Wasim Jafri, Ji-Dong Jia, Jia-Horng Kao, Kiyoshi Hasegawa, Patrick Lau, Jeong Min Lee, Jun Liang, Zhenwen Liu, Yinying Lu, Hongming Pan, Diana A. Payawal, Salimur Rahman, Jinsil Seong, Feng Shen, Gamal Shiha, Tianqiang Song, Hui-Chuan Sun, Tsutomu Masaki, Ekaphop Sirachainan, Lai Wei, Jin Mo Yang, Jose D. Sallano, Yanqiao Zhang, Tawesak Tanwandee, AKadir Dokmeci, Shu-sen Zheng, Jia fan, Sheung-Tat Fan, Shiv Kumar Sarin, Masao Omata
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management
- Guidelines
Akash Shukla, Don C. Rockey, Patrick S. Kamath, David E. Kleiner, Ankita Singh, Arun Vaidya, Abraham Koshy, Ashish Goel, A. Kadir Dökmeci, Babulal Meena, Cyriac Abby Philips, Chhagan Bihari Sharma, Diana A. Payawal, Dong Joon Kim, Gin-Ho Lo, Guohong Han, Huma Qureshi, Ian R. Wanless, Jidong Jia, Jose D. Sollano, Mamun Al Mahtab, Mark Dhinesh Muthiah, Mark W. Sonderup, Mendez Sanchez Nahum, Mohamed Ismail Bin Merican, Necati Ormeci, Norifumi Kawada, Rajender Reddy, R. K. Dhiman, Rino Gani, Saeed S. Hameed, Sidharth Harindranath, Wasim Jafri, Xiaolong Qi, Yogesh Kumar Chawla, Yoshihiro Furuichi, Ming-Hua Zheng, Shiv Kumar Sarin
Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects
- Review Article
Mohammed Ismail, Missaa M. Fadul, Reham Taha, Orwa Siddig, Muhanad Elhafiz, Bashir A. Yousef, Zhenzhou Jiang, Luyong Zhang, Lixin Sun
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD
- Original Article
Mingqian Jiang, Ziyan Pan, Jacob George, Mohammed Eslam
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
- Open Access
- Original Article
Maito Suoh, Saeed Esmaili, Mohammed Eslam, Jacob George
Incidence, risk factors, and outcomes of acute liver injury in hospitalized adults with acute kidney injury: a large multicenter study
- Original Article
Yuxin Lin, Pingping Li, Yuping Zhang, Qi Gao, Licong Su, Yanqin Li, Ruqi Xu, Yue Cao, Peiyan Gao, Fan Luo, Ruixuan Chen, Xiaodong Zhang, Sheng Nie, Xin Xu, Hong Xu, Bicheng Liu, Jianping Weng, Chunbo Chen, Huafeng Liu, Qiongqiong Yang, Hua Li, Yaozhong Kong, Guisen Li, Qijun Wan, Yan Zha, Ying Hu, Gang Xu, Yongjun Shi, Yilun Zhou, Guobin Su, Ying Tang, Mengchun Gong
Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristics
- Open Access
- Original Article
Nan Zhang, Zhaohui Li, Yutao Liu, Xiaohua Shi, Di Shi, Yue Li, Xiaoyan Si, Ziyu Xun, Jing Shao, Haitao Zhao, Hanping Wang
Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling
- Original Article
Ruobin Zong, Yan Zheng, Yufei Yan, Wenao Sun, Liangyi Kong, Yating Huang, Yujie Liu, Chaochen Jiang, Jie Ping, Changyong Li
Identification of PANoptosis-relevant subgroups and predicting signature to evaluate the prognosis and immune landscape of patients with biliary tract cancer
- Open Access
- Original Article
Dongming Liu, Wenshuai Chen, Zhiqiang Han, Yu Wang, Wei Liu, Aomei Ling, Qiang Wu, Huikai Li, Hua Guo
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy
- Open Access
- Original Article
Kuan-Chang Lai, Yen-Hao Chen, Yi‑Ping Hung, Nai-Jung Chiang, Ming‑Huang Chen, San-Chi Chen
Is laparoscopic hepatectomy superior to radiofrequency ablation in treating small hepatocellular carcinoma?
- Letter to the Editor
Dali Xiong, Jiaran Li, Shuanghu Yuan
Who better identifies significant liver fibrosis, MAFLD or MASLD, needs more rigorous, in-depth study
- Letter to the Editor
Haoxuan Zou, Xiaobin Sun